Skip to main content
Top
Published in: Breast Cancer Research and Treatment 1/2015

01-05-2015 | Epidemiology

No difference in the prevalence of benign breast changes between women from Ghana and Norway: an autopsy study

Authors: Helge Stalsberg, Ernest Kwasi Adjei, Osei Owusu-Afriyie

Published in: Breast Cancer Research and Treatment | Issue 1/2015

Login to get access

Abstract

Breast carcinoma develops gradually through multiple steps, some of which are recognizable as benign or premalignant histological changes. The age-standardized breast-cancer incidence rate is three times higher in Norway than in Ghana. A similar difference in the prevalence of benign and premalignant breast changes in the general populations would be expected if the difference in incidence rates were mainly due to cancer initiation factors, but not if it were caused by later stage promotion and progression factors. Breast tissue was taken by a standardized protocol from the autopsies of 44 Ghanaian and 26 Norwegian women between 15 and 60 years of age. Blind-labelled hematoxylin and eosin stained sections were examined independently by each of the three authors and the occurrence of histological changes in each section was recorded. The study revealed no significant difference between Norwegian and Ghanaian women in the prevalence of either proliferative or non-proliferative breast changes. The recorded incidence of breast cancer in Ghana may be under-estimated because of lower access to health services, lower patient awareness, and absence of population screening for breast cancer. Otherwise, the results support the conclusion that the lower incidence of breast cancer in Ghana than in Norway is mainly due to late-stage promotion and progression rather than initiation factors.
Literature
1.
go back to reference Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS (2010) Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 57:171–192CrossRefPubMed Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, Marchió C, Reis-Filho JS (2010) Breast cancer precursors revisited: molecular features and progression pathways. Histopathology 57:171–192CrossRefPubMed
2.
go back to reference Aulmann S, Braun L, Mietzsch F, Longerich T, Penzel R, Schirmacher P, Sinn HP (2012) Transitions between flat epithelial atypia and low-grade ductal carcinoma in situ of the breast. Am J Surg Pathol 36:1247–1252CrossRefPubMed Aulmann S, Braun L, Mietzsch F, Longerich T, Penzel R, Schirmacher P, Sinn HP (2012) Transitions between flat epithelial atypia and low-grade ductal carcinoma in situ of the breast. Am J Surg Pathol 36:1247–1252CrossRefPubMed
3.
go back to reference Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151CrossRefPubMed Dupont WD, Page DL (1985) Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312:146–151CrossRefPubMed
4.
go back to reference Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122:1053–1055PubMed Fitzgibbons PL, Henson DE, Hutter RV (1998) Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. Arch Pathol Lab Med 122:1053–1055PubMed
5.
go back to reference Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278CrossRefPubMed Lakhani SR (1999) The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 187:272–278CrossRefPubMed
6.
go back to reference Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S (2006) Molecular alterations in columnar cell lesions of the breast. Mod Pathol 19:344–349CrossRefPubMed Dabbs DJ, Carter G, Fudge M, Peng Y, Swalsky P, Finkelstein S (2006) Molecular alterations in columnar cell lesions of the breast. Mod Pathol 19:344–349CrossRefPubMed
7.
go back to reference Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734–746CrossRefPubMed Simpson PT, Gale T, Reis-Filho JS, Jones C, Parry S, Sloane JP, Hanby A, Pinder SE, Lee AH, Humphreys S, Ellis IO, Lakhani SR (2005) Columnar cell lesions of the breast: the missing link in breast cancer progression? A morphological and molecular analysis. Am J Surg Pathol 29:734–746CrossRefPubMed
8.
go back to reference Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055–1063PubMed Page DL, Vander Zwaag R, Rogers LW, Williams LT, Walker WE, Hartmann WH (1978) Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 61:1055–1063PubMed
9.
go back to reference Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477PubMed Carter CL, Corle DK, Micozzi MS, Schatzkin A, Taylor PR (1988) A prospective study of the development of breast cancer in 16,692 women with benign breast disease. Am J Epidemiol 128:467–477PubMed
10.
go back to reference Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B (1980) Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 65:13–20PubMed Hutchinson WB, Thomas DB, Hamlin WB, Roth GJ, Peterson AV, Williams B (1980) Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 65:13–20PubMed
11.
go back to reference Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2013) GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC CancerBase No. 11. International Agency for Research on Cancer, Lyon
12.
go back to reference Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR (1987) Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751–2760CrossRefPubMed Bartow SA, Pathak DR, Black WC, Key CR, Teaf SR (1987) Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study. Cancer 60:2751–2760CrossRefPubMed
13.
go back to reference Jensen HM, Rice JR, Wellings SR (1976) Preneoplastic lesions in the human breast. Science 191:295–297CrossRefPubMed Jensen HM, Rice JR, Wellings SR (1976) Preneoplastic lesions in the human breast. Science 191:295–297CrossRefPubMed
14.
go back to reference Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 56:814–819CrossRefPubMedCentralPubMed Nielsen M, Thomsen JL, Primdahl S, Dyreborg U, Andersen JA (1987) Breast cancer and atypia among young and middle-aged women: a study of 110 medicolegal autopsies. Br J Cancer 56:814–819CrossRefPubMedCentralPubMed
15.
go back to reference Sarnelli R, Squartini F (1991) Fibrocystic condition and “at risk” lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 18:271–279PubMed Sarnelli R, Squartini F (1991) Fibrocystic condition and “at risk” lesions in asymptomatic breasts: a morphologic study of postmenopausal women. Clin Exp Obstet Gynecol 18:271–279PubMed
16.
go back to reference Goehring C, Morabia A (1997) Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19:310–327CrossRefPubMed Goehring C, Morabia A (1997) Epidemiology of benign breast disease, with special attention to histologic types. Epidemiol Rev 19:310–327CrossRefPubMed
17.
go back to reference Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A (2008) Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer 113(8 Suppl):2338–2346CrossRefPubMed Stalsberg H, Awuah B, Ibarra JA, Nsiah-Asare A (2008) Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries. Cancer 113(8 Suppl):2338–2346CrossRefPubMed
18.
go back to reference Olu-Eddo AN, Ugiagbe EE (2011) Benign breast lesions in an African population: a 25-year histopathological review of 1864 cases. Niger Med J 52:211–216CrossRefPubMedCentralPubMed Olu-Eddo AN, Ugiagbe EE (2011) Benign breast lesions in an African population: a 25-year histopathological review of 1864 cases. Niger Med J 52:211–216CrossRefPubMedCentralPubMed
19.
go back to reference Ihekwaba FN (1994) Benign breast disease in Nigerian women: a study of 657 patients. J R Coll Surg Edinb 39:280–283PubMed Ihekwaba FN (1994) Benign breast disease in Nigerian women: a study of 657 patients. J R Coll Surg Edinb 39:280–283PubMed
20.
go back to reference Schuerch C 3rd, Rosen PP, Hirota T, Itabashi M, Yamamoto H, Kinne DW, Beattie EJ Jr (1982) A pathologic study of benign breast diseases in Tokyo and New York. Cancer 50:1899–1903CrossRefPubMed Schuerch C 3rd, Rosen PP, Hirota T, Itabashi M, Yamamoto H, Kinne DW, Beattie EJ Jr (1982) A pathologic study of benign breast diseases in Tokyo and New York. Cancer 50:1899–1903CrossRefPubMed
21.
go back to reference Aaman TB, Stalsberg H, Thomas DB (1997) Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO collaborative study of neoplasia and steroid contraceptives. Int J Cancer 71:333–339CrossRefPubMed Aaman TB, Stalsberg H, Thomas DB (1997) Extratumoral breast tissue in breast cancer patients: a multinational study of variations with age and country of residence in low- and high-risk countries. WHO collaborative study of neoplasia and steroid contraceptives. Int J Cancer 71:333–339CrossRefPubMed
22.
go back to reference Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827CrossRefPubMed Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AM, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827CrossRefPubMed
23.
go back to reference Kliewer EV, Smith KR (1995) Breast cancer mortality among immigrants in Australia and Canada. J Natl Cancer Inst 87:1154–1161CrossRefPubMed Kliewer EV, Smith KR (1995) Breast cancer mortality among immigrants in Australia and Canada. J Natl Cancer Inst 87:1154–1161CrossRefPubMed
24.
go back to reference Stoll BA (1999) Premalignant breast lesions: role for biological markers in predicting progression to cancer. Eur J Cancer 35:693–697CrossRefPubMed Stoll BA (1999) Premalignant breast lesions: role for biological markers in predicting progression to cancer. Eur J Cancer 35:693–697CrossRefPubMed
26.
go back to reference Adjei EK, Owusu-Afriyie O, Awuah B, Stalsberg H (2014) Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway. Breast J 20:308–311CrossRefPubMed Adjei EK, Owusu-Afriyie O, Awuah B, Stalsberg H (2014) Hormone receptors and Her2 expression in breast cancer in sub-Saharan Africa. A comparative study of biopsies from Ghana and Norway. Breast J 20:308–311CrossRefPubMed
27.
go back to reference Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110:183–188CrossRefPubMed Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C, Akang EE (2008) Immunohistochemical and molecular subtypes of breast cancer in Nigeria. Breast Cancer Res Treat 110:183–188CrossRefPubMed
28.
go back to reference Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De Blasio P, Mekki SO, Osman I, Biunno I, Elwali NE, Mariani-Costantini R, Barberis MC (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52:445–456CrossRefPubMed Awadelkarim KD, Arizzi C, Elamin EO, Hamad HM, De Blasio P, Mekki SO, Osman I, Biunno I, Elwali NE, Mariani-Costantini R, Barberis MC (2008) Pathological, clinical and prognostic characteristics of breast cancer in Central Sudan versus Northern Italy: implications for breast cancer in Africa. Histopathology 52:445–456CrossRefPubMed
29.
go back to reference Mbonde MP, Amir H, Akslen LA, Kitinya JN (2001) Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population. East Afr Med J 78:360–365CrossRefPubMed Mbonde MP, Amir H, Akslen LA, Kitinya JN (2001) Expression of oestrogen and progesterone receptors, Ki-67, p53 and BCL-2 proteins, cathepsin D, urokinase plasminogen activator and urokinase plasminogen activator-receptors in carcinomas of the female breast in an African population. East Afr Med J 78:360–365CrossRefPubMed
Metadata
Title
No difference in the prevalence of benign breast changes between women from Ghana and Norway: an autopsy study
Authors
Helge Stalsberg
Ernest Kwasi Adjei
Osei Owusu-Afriyie
Publication date
01-05-2015
Publisher
Springer US
Published in
Breast Cancer Research and Treatment / Issue 1/2015
Print ISSN: 0167-6806
Electronic ISSN: 1573-7217
DOI
https://doi.org/10.1007/s10549-015-3384-5

Other articles of this Issue 1/2015

Breast Cancer Research and Treatment 1/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine